🟢 Neumora Therapeutics is trading 8% up in after-hours trading — no clear catalyst identified

Neumora Therapeutics is trading 8% up now at $0.81 after closing September 17, 2026 at $0.75, with no fresh company-specific announcement or earnings release identified to explain the after-hours rebound.

• Available coverage points instead to earlier pipeline updates and continuing investor focus on its remaining programs.
• The move follows several sessions of steep declines, while broader markets rallied on September 17.
• Its cause remains unclear and could reflect thin extended-hours trading or broader risk appetite.